3rd Quarter - Report
LEAVITT PARTNERS, LLC for ALLIANCE FOR MRNA MEDICINES
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
The Alliance for mRNA Medicines (AMM) is dedicated to advancing and advocating for an RNA platform approach to medicine, including protein replacements, gene editing and cell engineering strategies, immunotherapies and vaccines to treat cancer, rare disease, autoimmunity and other chronic and infectious illnesses for the benefit of patients, public health, and society.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT CLAYTON ALSPACH | Chief Health Counsel for Chairman - House E&C Committee (E&C);Counsel - E&C, Clerk - E&C, and Paid Intern - E&C |
| SARA SINGLETON | Deputy Assistant Secretary-HHS; Policy Advisor- Senate; Legislative Assistant- Senate; Policy Fellow- Senate |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.